NIKITA ANDERSON: Open Payments
NPI 1174274997 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 28 payments from 8 companies in 2025. Trend: 2023 $142 · 2024 $388 · 2025 $1,059
Food & beverage: $1,054Travel & lodging: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $206 |
| Janssen Biotech, Inc. | 5 | $204 |
| COLOPLAST CORP | 3 | $190 |
| Dendreon Pharmaceuticals LLC | 2 | $174 |
| ABBVIE INC. | 4 | $141 |
| UROGEN PHARMA, INC. | 5 | $107 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $18 |
| TOLMAR, INC. | 1 | $18 |
Products named: PROVENGE, GEMTESA, BOTOX, RYBREVANT, Altis, ERLEADA, SpeediCath, ORGOVYX.
Industry payments across AL — which companies pay providers there.
